1-3 of 3
Theofanis Apostolou
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Renal Outcomes in Patients with AL Amyloidosis: Evaluation of Prognostic Factors and Impact of Therapy with Novel Agents

Efstathios Kastritis, MD, Maria Roussou, Evangelos Terpos, Maria Gavriatopoulou, Evangelos Eleutherakis-Papaiakovou, Despoina Kalapanida, Sofoklis Kontogiannis, Theofanis Apostolou, Ioannis Boletis, Constantinos Pamboukas, Savvas Th. Toumanidis, Elektra Papadopoulou, Erasmia Psimenou, Meletios A. Dimopoulos, MD
Journal: Blood
Blood (2014) 124 (21): 2130.
https://doi.org/10.1182/blood.V124.21.2130.2130
Published: 2014
Journal Articles

A phase 1/2 study of lenalidomide with low-dose oral cyclophosphamide and low-dose dexamethasone (RdC) in AL amyloidosis

Clinical Trials & Observations
Efstathios Kastritis, Evangelos Terpos, Maria Roussou, Maria Gavriatopoulou, Constantinos Pamboukas, Ioannis Boletis, Smaragda Marinaki, Theofanis Apostolou, Nikitas Nikitas, Georgios Gkortzolidis, Eurydiki Michalis, Sossana Delimpasi, Meletios A. Dimopoulos
Journal: Blood
Blood (2012) 119 (23): 5384–5390.
https://doi.org/10.1182/blood-2011-12-396903
Published: 2012
Includes: Supplemental data
Journal Articles

Phase I/II Study of Lenalidomide, Intermediate Dose Dexamethasone and Low Dose Cyclophosphamide (RDC) for the Treatment of Patients with Primary Systemic Amyloidosis (AL).

Efstathios Kastritis, Flora Zagouri, Maria Roussou, Magdalini Migkou, John Boletis, Theofanis Apostolou, Meletios A. Dimopoulos
Journal: Blood
Blood (2008) 112 (11): 1734.
https://doi.org/10.1182/blood.V112.11.1734.1734
Published: 2008